Chemoinformaics analysis of ERIODICTYOL-7-RUTINOSIDE
| Molecular Weight | 596.538 | nRot | 6 |
| Heavy Atom Molecular Weight | 564.282 | nRig | 30 |
| Exact Molecular Weight | 596.174 | nRing | 5 |
| Solubility: LogS | -3.411 | nHRing | 3 |
| Solubility: LogP | -0.848 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 74 | No. of Aliphatic Hetero Cycles | 3 |
| No. of Heavy Atom | 42 | No. of Aromatic Carbocycles | 2 |
| nHetero | 15 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 27 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 15 | No. of Arom Bond | 12 |
| nHA | 15 | APOL | 78.4574 |
| nHD | 9 | BPOL | 41.6506 |
| QED | 0.173 |
| Synth | 4.845 |
| Natural Product Likeliness | 2.04 |
| NR-PPAR-gamma | 0.964 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.979 |
| HIA | 0.946 |
| CACO-2 | -6.543 |
| MDCK | 0.00007 |
| BBB | 0.241 |
| PPB | 0.846233 |
| VDSS | 0.421 |
| FU | 0.194795 |
| CYP1A2-inh | 0.004 |
| CYP1A2-sub | 0.025 |
| CYP2c19-inh | 0.015 |
| CYP2c19-sub | 0.063 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.383 |
| CYP2d6-inh | 0.013 |
| CYP2d6-sub | 0.191 |
| CYP3a4-inh | 0.014 |
| CYP3a4-sub | 0.025 |
| CL | 1.643 |
| T12 | 0.287 |
| hERG | 0.009 |
| Ames | 0.543 |
| ROA | 0.127 |
| SkinSen | 0.064 |
| Carcinogencity | 0.82 |
| EI | 0.011 |
| Respiratory | 0.035 |
| NR-Aromatase | 0.465 |
| Antiviral | Yes |
| Prediction | 0.851405 |